Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeutics

Neuro Oncol. 2020 Dec 18;22(12):1713-1714. doi: 10.1093/neuonc/noaa242.

Authors

Kasey R Skinner^{1

2

3}, L Burt Nabors^{4

5

6

3}, C Ryan Miller^{2

5

6

3}

Affiliations

¹ Neuroscience Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
² Division of Neuropathology, Department of Pathology.
³ University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
⁴ Division of Neuro-Oncology, Department of Neurology.
⁵ O'Neal Comprehensive Cancer Center.
⁶ Comprehensive Neurosciences Center.

No abstract available

MeSH terms

Brain Neoplasms* / genetics
Brain Neoplasms* / therapy
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Glioblastoma* / genetics
Glioblastoma* / therapy
Humans
Transcriptome

Grants and funding

F31 CA247177/CA/NCI NIH HHS/United States